Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis

Annals of Nuclear Medicine

Volumn 14, Issue 5, 2000, Pages 395-399

  Arslan, Nuri ^a,b   Serdar, Muhittin ^a,b   Deveci, Sallh ^a,b   Ozturk, Bekir ^a   Narin, Yavuz ^a,b   Ilgan, Seyfettin ^a,b   Ozturk, Emel ^a,b   Ozguven, M Ali ^a,b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Department of Pediatrics Medical Faculty   (Turkey)

Author keywords

Breast cancer; Primary diagnosis; Prognostic factor; Tumor markers

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROLACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0033661871     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988705     Document Type: Article

References (11)

1. The epidemiology of breast cancer
2. Use of tumour markers in certain solid tumors
3. Comparison of prolactin, CA 15-3 and TPA in breast carcinomas
4. Cancer of the breast
5. Hormones as cancer growth factors
6. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer
7. The role of CA 15.3 and MCA monoclonal-antibody assays in the detection of primary and recurrent breast cancer
8. Circulating tumor marker levels in advanced breast cancer carcinoma correlation with the extent of metastatic disease
9. Value of CA 15-3 in the follow-up of breast cancer patients
10. An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma
11. Comparison of circulating CA 15- 3 and carcinoembryonic antigen levels in patients with breast cancer